shutterstock_339308225

Deeper patient insights for stronger patient outcomes

pharmafile | October 28, 2019 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  eyeforpharma, pharma 

Patient insights are crucial. As you already know, they are the key to the creation of successful, targeted programmes and even brand-new product offerings. They dictate the delivery of successful outcomes.

But if we are to gain deeper, richer insights, we must construct frameworks that help more patients articulate their value-drivers and hit on critical touchpoints.

That’s why at eyeforpharma we’ve put together a webinar (2pm GMT/9am EST, 6 November), with an expert panel, to provide pragmatic tools on how to build smarter frameworks for new understanding that leads to targeted, personalised services, and ultimately, greater outcomes.

The panel includes: Daniel De Schryver (Patient Engagement and Advocacy Lead, EMEA, Janssen); Clare Moloney (Programme Insights & Design Lead, IQVIA); Desiree Priestley (Director, Patient Support Strategy & Insights, Otsuka); Oliver Gassner (Head, Digital Health Intelligence, EMEA, Bayer); and Teresa Ferreiro (Patient Advocate & eyeforpharma Award Winner)

Advertisement

By joining, you’ll learn:

  • Why designing frameworks with the patient in mind is insufficient: Work with patients from the beginning to ensure you collect comprehensive and pertinent insights
  • How to build your business case: Use insights to outline the commercial imperative of new services
  • It’s not just patients: When and how to engage HCPs and carers to gather a holistic view on how programmes can best operate

We look forward to a webinar that promises practical advice on how to vastly improve the likelihood of success when building new programmes that deliver maximum patient value.

Registrations are now open here: http://bit.ly/2BEBq13

*All signups receive the recording – so if you can’t make it on the day, sign up anyway and you’ll get the on-demand version

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content